Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

1.3K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.5K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to: "Refining Combined-Modality Therapy and Charting the Future of Primary Vitreoretinal Lymphoma".

American journal of hematology·2026
Same author

Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity.

Cancers·2026
Same author

Combination of Ocular Radiation With Systemic Chemotherapy for Treatment of Primary Vitreoretinal Lymphoma: A Prospective Single Center Cohort With Long Follow-Up.

American journal of hematology·2026
Same author

CIPHER-seq enables intracellular multimodal profiling of cytokine responses in single immune cells.

Scientific reports·2026
Same author

Predictors and timing of venous thromboembolism and overall survival in lymphoma.

Leukemia & lymphoma·2026
Same author

Racial and clinical determinants of response in 2304 large B-cell lymphomas treated with CD19 CAR T in clinical trials.

Blood advances·2025

Related Experiment Video

Updated: Nov 9, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.9K

Potency Meets Precision in Nano-optimized Chemotherapeutics.

Artavazd Arumov1, Asaad Trabolsi2, Jonathan H Schatz3

  • 1Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL, USA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Trends in Biotechnology
|April 9, 2021
PubMed
Summary

Nanotechnology enhances chemotherapy drugs, transforming generic treatments into precise medicines. This approach shows promise for treating diffuse large B-cell lymphoma (DLBCL), a common blood cancer.

Keywords:
cancerdrug deliverylymphomananotechnologyprecision medicinetherapeutics

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.2K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.2K

Related Experiment Videos

Last Updated: Nov 9, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.9K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.2K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.2K

Area of Science:

  • Oncology
  • Nanomedicine
  • Biotechnology

Background:

  • Chemotherapy is a primary cancer treatment.
  • Generic chemotherapy drugs have limitations.
  • Nanotechnology offers novel drug delivery solutions.

Purpose of the Study:

  • To explore nanotechnology's role in enhancing chemotherapy.
  • To focus on diffuse large B-cell lymphoma (DLBCL) treatment.
  • To highlight recent advances in nanomedicine for hematologic malignancies.

Main Methods:

  • Review of recent advancements in nanotechnology-enhanced chemotherapy.
  • Focus on applications in diffuse large B-cell lymphoma models.
  • Analysis of nanotechnology's potential to improve drug efficacy and precision.

Main Results:

  • Nanotechnology can significantly improve chemotherapy drug delivery and targeting.
  • Enhanced therapies show potential for overcoming limitations of traditional chemotherapy.
  • Specific examples of nanotechnology applications in DLBCL treatment are discussed.

Conclusions:

  • Nanotechnology represents a significant advancement in cancer therapy.
  • Nanomedicine offers a pathway to more precise and effective treatments for DLBCL.
  • Further research into nanotechnology-enhanced chemotherapy is warranted for various hematologic malignancies.